The HSE have released a document laying out the HSE’s position on the use of antiretroviral therapy (including TasP) for HIV infected people attending HIV services in Ireland. In it the HSE recommends that all HIV infected individuals attending HIV services in Ireland are offered antiretroviral therapy as soon as possible and are informed of the benefits of antiretroviral therapy in reducing HIV infectiousness (TasP) and improving personal health.
The overarching vision of Ireland’s first sexual health strategy, launched in October 2015, was to improve sexual health and wellbeing and reduce negative sexual health outcomes. With respect to HIV, action was called to reduce the number of new infections and ensure the health and wellbeing of those living with HIV. These requirements were reflected in two of the priority actions in the strategy, specifically:
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
